Kentaro Kubo

1.2k total citations
65 papers, 898 citations indexed

About

Kentaro Kubo is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rehabilitation. According to data from OpenAlex, Kentaro Kubo has authored 65 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Surgery, 25 papers in Pulmonary and Respiratory Medicine and 14 papers in Rehabilitation. Recurrent topics in Kentaro Kubo's work include Esophageal Cancer Research and Treatment (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Esophageal and GI Pathology (17 papers). Kentaro Kubo is often cited by papers focused on Esophageal Cancer Research and Treatment (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Esophageal and GI Pathology (17 papers). Kentaro Kubo collaborates with scholars based in Japan, United States and United Kingdom. Kentaro Kubo's co-authors include Yoshimitsu Kuroyanagi, Toshio Inui, Yoshitaka Maki, Hideaki Nagaya, Yoshihiro Uto, Takahito Nishikata, Norihiro Sakamoto, Hitoshi Hori, Shizuko Kagawa and Tsuyoshi Nishi and has published in prestigious journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Journal of Experimental Biology.

In The Last Decade

Kentaro Kubo

58 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kentaro Kubo Japan	17	292	263	179	170	119	65	898
Michael Dobryansky United States	13	503 1.7×	362 1.4×	299 1.7×	162 1.0×	86 0.7×	18	1.2k
Tatyana Yufit United States	12	606 2.1×	284 1.1×	273 1.5×	217 1.3×	68 0.6×	18	1.3k
Rica Tanaka Japan	19	457 1.6×	354 1.3×	521 2.9×	163 1.0×	99 0.8×	58	1.5k
H. Peter Lorenz United States	15	397 1.4×	191 0.7×	177 1.0×	149 0.9×	93 0.8×	31	835
Wan Xing Hong United States	13	426 1.5×	201 0.8×	395 2.2×	226 1.3×	186 1.6×	25	1.2k
Susanne Schatz Germany	4	382 1.3×	181 0.7×	266 1.5×	114 0.7×	96 0.8×	4	1.1k
Barrett J. Larson United States	9	316 1.1×	147 0.6×	565 3.2×	142 0.8×	123 1.0×	14	1.3k
Loubna Mazini Morocco	13	232 0.8×	255 1.0×	538 3.0×	165 1.0×	129 1.1×	19	1.3k
Céline Auxenfans France	19	203 0.7×	206 0.8×	168 0.9×	162 1.0×	145 1.2×	50	963
Joshua Tam United States	15	167 0.6×	327 1.2×	384 2.1×	258 1.5×	236 2.0×	46	1.3k

Countries citing papers authored by Kentaro Kubo

Since Specialization

Citations

This map shows the geographic impact of Kentaro Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Kubo more than expected).

Fields of papers citing papers by Kentaro Kubo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Kubo. The network helps show where Kentaro Kubo may publish in the future.

Co-authorship network of co-authors of Kentaro Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Kubo. A scholar is included among the top collaborators of Kentaro Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Kubo. Kentaro Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujita, Takeo, Koshiro Ishiyama, Daisuke Kurita, et al.. (2025). Oncological outcomes of thoracic duct preservation and resection for esophageal carcinoma based on an understanding of its surgical microanatomy in the era of minimally invasive esophagectomy and neoadjuvant chemotherapy. European Journal of Surgical Oncology. 51(8). 110062–110062. 1 indexed citations

Kubo, Kentaro, Daisuke Kurita, Shun Yamamoto, et al.. (2025). Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma. Diseases of the Esophagus. 38(1). 1 indexed citations

Fujita, Takeo, et al.. (2025). Short-term outcomes of robot-assisted transcervical esophagectomy for thoracic esophageal carcinoma. Surgical Endoscopy. 39(9). 5733–5741.

Inui, Toshio, et al.. (2024). Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial. BMC Infectious Diseases. 24(1). 519–519. 1 indexed citations

Daiko, Hiroyuki, et al.. (2024). Bilateral transcervical mediastinoscopic-assisted transhiatal laparoscopic esophagectomy compared with thoracolaparoscopic esophagectomy for esophageal cancer: a propensity score-matched analysis. Surgical Endoscopy. 38(10). 5746–5755. 1 indexed citations

Daiko, Hiroyuki, Koshiro Ishiyama, Daisuke Kurita, et al.. (2024). Technical feasibility and oncological outcomes of robotic esophagectomy compared with conventional thoracoscopic esophagectomy for clinical T3 or T4 locally advanced esophageal cancer: a propensity-matched analysis. Surgical Endoscopy. 38(7). 3590–3601. 5 indexed citations

Kubo, Kentaro, et al.. (2024). Association between preoperative serum zinc level and prognosis in patients with advanced esophageal cancer in the neoadjuvant treatment era. Annals of Gastroenterological Surgery. 8(4). 595–603.

Fujii, Yusuke, Hiroyuki Daiko, Kentaro Kubo, et al.. (2023). Non-curative resection for surgical T4b esophageal cancer: esophagectomy or non-esophagectomy?. Langenbeck s Archives of Surgery. 408(1). 201–201. 5 indexed citations

Kubo, Kentaro, Daisuke Kurita, Shun Yamamoto, et al.. (2023). Significance of Surgery for Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma in the Era of Neoadjuvant Treatment. Annals of Surgical Oncology. 31(3). 1525–1535. 12 indexed citations

10.

Oguma, Junya, Koshiro Ishiyama, Daisuke Kurita, et al.. (2023). Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa. Surgery. 173(5). 1162–1168. 1 indexed citations

11.

Kubo, Kentaro, Junya Oguma, Yusuke Fujii, et al.. (2022). Clinicopathological Features of Early-Stage Esophageal Carcinosarcoma. Case Reports in Gastroenterology. 16(3). 569–576. 1 indexed citations

12.

Oguma, Junya, Koshiro Ishiyama, Daisuke Kurita, et al.. (2021). Novel pathological staging for patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by surgery. Esophagus. 19(2). 214–223. 7 indexed citations

13.

Ishiyama, Koshiro, et al.. (2021). Salvage minimally invasive esophagectomy after definitive chemoradiotherapy for esophageal cancer can improve postoperative complications compared with salvage open esophagectomy. Surgical Endoscopy. 36(5). 3504–3510. 7 indexed citations

14.

Kubo, Kentaro, Daisuke Kurita, Koshiro Ishiyama, et al.. (2021). Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma. Japanese Journal of Clinical Oncology. 51(8). 1225–1231. 4 indexed citations

15.

Kurozumi, Sasagu, Kenichi Inoue, Hideyuki Matsumoto, et al.. (2016). Abstract P4-14-17: Prognostic value of tumor-infiltrating lymphocytes in residual tumors after neoadjuvant chemotherapy concomitant with trastuzumab for HER2-positive breast cancer. Cancer Research. 76(4_Supplement). P4–14. 1 indexed citations

16.

Katoh, Masakazu, et al.. (2009). Morphological Characterization of a Reconstructed, Cultured Human Epidermal Model (LabCyte EPI-MODEL) As an Alternative to in Vivo Models. 14(2). 873–878. 1 indexed citations

17.

Tanizaki, Hideaki, et al.. (2007). Clinical study with allogeneic cultured dermal substitutes for chronic leg ulcers. International Journal of Dermatology. 46(1). 36–42. 26 indexed citations

18.

Ueda, Koichi, et al.. (2006). Skin Regeneration for Children With Burn Scar Contracture Using Autologous Cultured Dermal Substitutes and Superthin Auto-Skin Grafts. Annals of Plastic Surgery. 57(4). 408–414. 16 indexed citations

19.

Hasegawa, Toshio, Yasushi Suga, Masayuki Mizoguchi, et al.. (2005). An Allogeneic Cultured Dermal Substitute Suitable for Treating Intractable Skin Ulcers and Large Skin Defects Prior to Autologous Skin Grafting: Three Case Reports. The Journal of Dermatology. 32(9). 715–720. 23 indexed citations

20.

Kubo, Kentaro & Yoshimitsu Kuroyanagi. (2004). Development of a Cultured Dermal Substitute Composed of a Spongy Matrix of Hyaluronic Acid and Atelo‐collagen Combined with Fibroblasts: Cryopreservation. Artificial Organs. 28(2). 182–188. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact